Literature DB >> 3947520

The diagnosis and treatment of adults with obstructive airways disease in general practice.

A G Wardman, V Binns, A D Clayden, N J Cooke.   

Abstract

Two hundred and one patients diagnosed by their general practitioners as having asthma and 113 as having chronic bronchitis were compared by symptomatology and airways reversibility. Though the majority of patients given these two diagnoses could be separated by symptom complex, in about one-third such differentiation was difficult. There was no significant difference in bronchodilator reversibility between the asthmatics and chronic bronchitics. Nine out of 15 (60%) asthmatics and four out of 18 (22%) chronic bronchitics responded by 15% or more to a course of oral corticosteroid drugs. The majority of corticosteroid responders had been undertreated. The problems arising from the poor correlation between airways reversibility and symptomatic diagnosis are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3947520     DOI: 10.1016/0007-0971(86)90005-7

Source DB:  PubMed          Journal:  Br J Dis Chest        ISSN: 0007-0971


  5 in total

1.  Cross-sectional observations on the natural history of asthma.

Authors:  R G Neville; C McCowan; G Hoskins; G Thomas
Journal:  Br J Gen Pract       Date:  2001-05       Impact factor: 5.386

2.  Prevalence and diagnosis of chronic respiratory symptoms in adults.

Authors:  P Littlejohns; S Ebrahim; R Anderson
Journal:  BMJ       Date:  1989-06-10

3.  Treatment of adult asthma: is the diagnosis relevant?

Authors:  P Littlejohns; S Ebrahim; R Anderson
Journal:  Thorax       Date:  1989-10       Impact factor: 9.139

4.  Validity of peak expiratory flow measurement in assessing reversibility of airflow obstruction.

Authors:  F W Dekker; A C Schrier; P J Sterk; J H Dijkman
Journal:  Thorax       Date:  1992-03       Impact factor: 9.139

5.  Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group.

Authors:  P L Brand; P H Quanjer; D S Postma; H A Kerstjens; G H Koëter; P N Dekhuijzen; H J Sluiter
Journal:  Thorax       Date:  1992-06       Impact factor: 9.139

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.